Now Playing

Amgen To Buy Onyx In $10.4 Billion Deal

There's been a major acquisition in the drug industry. Amgen Inc, the world's largest biotechnology company is buying Onyx Pharmaceuticals. The deal is valued at $10.4 billion. Amgen has high hopes for Onyx's cancer drugs.

Trouble listening? See our technical support page.